Alvin H. Moss, MD, FACP, FAAHPM

1. Gonatas NK, Moss AH. Pathologic axons and synapses in human neuropsychiatric disorders. Human Path 1975; 6:571-582.

2. Moss AH, Solomons CC, Alfrey AC. Elevated plasma adenine nucleotide levels in chronic renal failure and their possible significance. Proc Clin Dial Transpl Forum 1979; 9:184-188.

3. Moss AH, Gabow A, Kaehny WD, et al. Fanconi's syndrome and distal renal tubular acidosis after glue sniffing.

4. Syndromes of toluene sniffing in adults. Ann Intern Med 1981; 94:758-762.

5. Moss AH, Peterson LJ, Scott OM, et al. Delayed diagnosis of juxtaglomerular cell tumor hypertension. North Car Med J 1982; 43:795-797.

6. Knapp DD, Moss AH. The spectrum of hemolytic-uremic syndrome. WV Med J 1985; 81:197-200.

7. Lempert KD, Baltz P, Graves JW, Moss AH, Whittier FC. Use of the polyacrylonitrile membrane in continuous hemofiltration. ASAIO Journal 1985; 8:228-233.

8. Kenamond TG, Graves JW, Lempert KD, Moss AH, Whittier FC. Severe recurrent alkalemia in a continuous cyclic peritoneal dialysis patient. Am J Med 1986; 81:548-550.

9. Moss AH. Renal colic, arthralgia in a hypercalcemic man. Hosp Prac 1985; 20:31-32.

10. Moss AH, McLaughlin MM, Lempert KD, Holley JL. Short-term vascular access for hemodialysis using a silicone dual lumen catheter with a Dacron cuff. Am J Kidney Dis 1988; 12:492-498.

11. Holley JL, Moss AH. A prospective evaluation of blood versus standard plate techniques for diagnosing peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1989; 13:184-188.

12. Holley JL, Finucane TE, Moss AH. Dialysis patients' attitudes about cardiopulmonary resuscitation and stopping dialysis. Am J Neph 1989; 9:245-251.

13. Moss AH. Informing the patient about cardiopulmonary resuscitation: When the risks outweigh the benefits.

14. Upper extremity ischemic monomelic neuropathy: a complication of vascular access procedures in uremic diabetic patients. Neurology 1989; 39:997-998.

15. Holley JL, Foulks CJ, Moss AH, Willard D. Ultrasound as a tool in the diagnosis and management of exit-site infections in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1989; 14:211-216.

16. Moss AH, Hamrick RM III, Shen H-S. Limulus amebocyte lysate reactivity, complement activation and patient's symptoms: comparison of two dialyzer membranes. ASAIO Trans. 1989; 35:812-815.

17. Moss AH, Vasilakis C, Holley JL, Foulks CJ, Pillai K, McDowell D. Use of a silicone dual lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 1990; 16:211-215.

l8. Moss AH, Cassel CK. What are the important ethical issues in chronic dialysis? Semin Dial 1990; 3:213-215.

l9. Moss AH. What West Virginia physicians need to know about advance directives. WV State Medical Journal 1991;87:7-9.

20. Moss AH, Siegler M. Should alcoholics compete equally for liver transplantation? JAMA 1991; 265:1295-1298.

2l. Moss AH. Ethics and End Stage Renal Disease: A Life-Cycle Perspective. Nephrology Nursing Today 1991; 1:1-7.

22. Foulks CJ, Holley JL, Moss AH. Nephrologists' reported attitudes about factors influencing recommendations to initiate or withdraw dialysis. J Am Soc Nephrol 1991; Vol. 1: 1284-8.

23. Moss AH. Therapy for diabetic gastroparesis. Semin Dial 1991; 4:125-6.

24. Foulks CJ, Holley JL, Moss AH. The use of CPR: How nephrologists and internists differ. Am J Kidney Dis 1991; 28:379-83.

25. Moss AH. The patient self-determination act: benefit or burden? West Virginia Medical Journal 1991; 87:510-513.

26. Rettig RA, Cassel CK, Moss AH. Is it time again for patient selection criteria? an IOM view. Nephrol News and Issues 1992; 6:21-23.

27. Maciunas KA, Moss AH. Learning the patient's narrative to determine decision-making capacity: the role of ethics consultation. J Clin Ethics, 1992; 3:287-9.

28. Moss AH, Holley JL, Upton MB. Outcomes of cardiopulmonary resuscitation in dialysis patients. J Am Soc Nephrol 1992; 3:238-43.

29. Moss AH, Heidkamp PC, Stocking CB, Roos R, Brooks BR, Siegler M. Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family and physician attitudes. Neurology 1993; 43:438-443.

30. Moss AH. Discussing resuscitation status with patients and families. J Clin Ethics 1993; 4:180-182.

31. Moss AH. Kelly PD, DeLaura G. How the Health Care Surrogate Act of 1993 will simplify medical care in West Virginia. West Virginia Medical Journal 1993; 89:274-275.

32. Moss AH. Should a dialysis unit be bound to treating a non-compliant patient? Nephrology News and Issues 1993; 7:21-22.

33. Moss AH. Know the law regarding the DNR Act! West Virginia Medical Journal 1993; 89:394.

34. McDowell DE, Moss AH, Vasilakas C, Bell R, Pillai L. Percutaneously-placed dual-lumen silicone catheters for long-term hemodialysis. Am Surgeon 1993; 59:569-573.

35. Moss AH, Rettig, RA, Cassel, CK. A proposal for guidelines for patient acceptance to and withdrawal from dialysis: a follow-up to the Institute of Medicine ESRD Report. ANNA Journal 1993; 20:557-561.

36. Moss AH, Stocking CB, Sachs GA, Siegler M. Variations in the attitudes of dialysis unit directors' toward decisions to withhold and withdraw dialysis. J Am Soc Nephrol 1993; 4:229-234.

37. Moss AH. Dialysis decisions and the elderly. Clinics in Geriatric Medicine 1994; 10:463-473.

38. Keating RF, Moss AH, Sorkin MI, Paris JJ. Stopping dialysis of an incompetent patient over the family's objection: is it ever ethical? J Am Soc Nephrol 1994; 4:1879-8.

39. Paris JJ, Moss AH. Guidelines on use of renal dialysis. Clinical Ethics Report 1993;7:1-5.

40. Moss AH, MacKay K. Deciding resuscitation status with dialysis patients and their families: a tale of two cases. Sem Dial 1994; 7:347-350.

41. Weinstein BD, Moss AH. Role models. JAMA 1995; 273:1076.

42. Stamatakis MK, Sorkin MI, Moss AH. Toxicity following IP trimethoprim-sulfamethoxazole in a CAPD patient. Peritoneal Dialysis International 1995; 15:180-181.

43. Moss AH. To use dialysis appropriately: the emerging consensus on patient selection guidelines. Advances in Renal Replacement Therapy 1995; 2:175-183.

44. Johnson CC, Moss AH, Clarke SAD, Armistead NC. Working with noncompliant and abusive patients: practical strategies based on ethics and the law. Advances in Renal Replacement Therapy 1996; 3:77-86.

45. Moss AH, Oppenheimer EA, Casey P, Cazzolli PA, Roos RP, Stocking CB, Siegler M. Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation: advance care planning and outcomes. CHEST 1996; 110:249-255.

46. Moss AH. The impending legalization of physician-assisted suicide: how should physicians respond. West Virginia State Medical Journal 1996; 92:182-183.

47. Moss AH. Physician-assisted suicide: a care option for dying patient? Nephrology News and Issues 1996; 10: 42-44.

48. MacKay K, Moss AH. Acute dialysis of patients with multiple organ dysfunction syndrome: should it be done? Seminars in Dialysis 1996; 9:412-416.

49. Shreves J, Moss AH. Residents’ ethical disagreements with attending physicians: an unrecognized problem. Academic Medicine 1996; 71:11-3-1105.

50. Brady L, Logemann J, Moss AH. What if a patient refuses treatment? ASHA, Summer 1997: 52-56.

51. Hines SC, Babrow AS, Badzek L, Moss AH. Communication and problematic integration in end-of-life decisions: dialysis decisions among the elderly. Health Communication 1997; 9:199-217.

52. Hines SC, Badzek LA, Moss AH. Informed consent among chronically ill elderly: assessing its (In) adequacy and predictors. Journal of Applied Communication Research 1997; 25: 151-169.

53. MacKay K, Moss AH. To dialyze or not to dialyze: an ethical and evidence-based approach to the patient with acute renal failure in the intensive care unit. Advances in Renal Replacement Therapy, 1997; 4:288-296.

54. Hines S, Moss AH, McKenzie J. Prolonging life or prolonging death: communication's role in difficult dialysis decisions. Health Communication 1997; 9:369-388.

55. McKenzie JK, Moss AH, Feest TG, Stocking CB, Siegler M. Dialysis decision making in Canada, the United Kingdom, and the United States. American Journal of Kidney Diseases 1998; 31:12-18.

56. Sekkarie, MA, Moss, AH. Withholding and withdrawing dialysis: the role of physician specialty and education and patient functional status. American Journal of Kidney Diseases 1998; 31:464-472.

57. Hines SC, Moss AH, Badzek LA. Being involved or just being informed? Communication preferences of seriously ill, older adults. Communication Quarterly 1997; 45:268-281.

58. Moss AH. At least we do not feel guilty: managing conflict with families over dialysis discontinuation. American Journal of Kidney Diseases 1998; 31:868-883.

59. Moss AH, DeLaura G, Gallagher B. The Management of Intractable Pain Act: what will it mean for physicians and patients in West Virginia? West Virginia Medical Journal 1998; 94:134-135.

60. Badzek LA, Hines SC, Moss AH. Inadequate self-care knowledge among elderly hemodialysis patients: assessing its prevalence and potential causes. ANNA Journal 1998; 25: 293-300.

61. Glover JJ, Moss AH. Rationing dialysis in the United States: possible implications of capitated systems. Advances in Renal Replacement Therapy 1998; 5:341-349.

62. Holley JL, Hines SC, Glover, JJ, Babrow AS, Badzek LA, Moss AH. Failure of advance care planning to elicit patients’ preferences for withdrawal from dialysis. Am J Kidney Dis 1999; 33:688-693.

63. Hines SC, Glover JJ, Holley JL, Babrow AS, Badzek LA, Moss AH. Dialysis patients’ preferences for advance care planning and end-of-life decision making. Ann Intern Med 1999; 130:825-828.

64. Moss AH. The application of the task force report in rural and frontier settings. Journal of Clinical Ethics 1999; 10:42-48.

65. Warren SC, Hines SC, Moss AH. Concerns and self-reported competencies in end-of-life care: a survey of physicians in WV. West Virginia Medical Journal 2000; 96:455-457.

66. Moss AH. A new clinical practice guideline on initiation and withdrawal of dialysis that makes explicit the role of palliative of medicine. Journal of Palliative Medicine 2000; 3:253-260.

67. Moss AH, DeLaura G. The impact of the new West Virginia Health Care Decisions Act. West Virginia Medical Journal 2000, 96:499-500.

68. Sial VA, Moss AH. Pain management for end-of-life care. West Virginia Medical Journal 2000; 96:556-558.

69. Badzek LA, Cline HS, Moss AH, Hines SC. Inappropriate use of dialysis for some elderly patients: nephrology nurses’ perceptions and concerns. Nephrology Nursing Journal 2000; 27:462-470.

70. Moss AH. Recent advances in end-of-life care. West Virginia Medical Journal 2000; 96:608-609.

71. Moss AH. Measuring the quality of dying. Journal of Palliative Medicine 2001; 4:149-151.

72. Moss AH. Shared decision making in dialysis: the new RPA/ASN guideline on appropriate initiation and withdrawal of treatment. American Journal of Kidney Diseases 2001; 37:1081-1091.

73. Moss AH, DeLaura G, Arnold RC. New WV Board of Medicine policy statement on pain management at the end of life. West Virginia Medical Journal 2001; 97: 160-161.

74. Moss AH. The need for more physician communication with patients/families facing the end of life. West Virginia Medical Journal 2001;98:206-208.

75. Moss AH, Hozayen O, King K, Holley JL, Schmidt RJ. Attitudes of patients toward cardiopulmonary resuscitation in the dialysis unit. Am J Kidney Dis 2001;38:847-852.

76. Moss AH. Billing procedures and reimbursement for palliative care consultations. West Virginia Medical Journal 2001;97:260-261.

77. Moss AH. New guideline describes nephrology community consensus on withholding and withdrawing dialysis. Nephrology News and Issues 2001;15 (11):50-57.

78. Moss AH. New guideline describes nephrology community consensus on withholding and withdrawing dialysis: Recommendations regarding withdrawing dialysis. Nephrology News and Issues 2001;15 (12):58-61.

79. Moss AH. New guideline describes nephrology community consensus on withholding and withdrawing dialysis: Recommendations regarding conflict resolution and forgoing dialysis in special patient populations. Nephrology News and Issues 2001;15 (13):51-54.

80. Moss AH. Measuring the quality of dying [Editorial]. J Palliat Med 2001;4:149-151.

81. Hines SC, Glover JJ, Babrow AS, Holley JL, Badzek LA, Moss AH. Improving advance care planning by accommodating family preferences. J Palliat Med 2001; 4:481-489.

82. Moss AH. Patient-centered medicine: Achieving outcomes in end-of-life care that will meet with high patient and family satisfaction. WV Med J 2001;97:306-307.

83. Moss AH. Shared decision making in dialysis: a new clinical practice guideline to assist with dialysis-related ethics consultations. Journal of Clinical Ethics 2001; 12(4):406-414.

84. Moss AH. Update on pain management in West Virginia: New legislation encourages pain control of dying patients’ pain. WV Med J 2002;98:100-103.

85. Moss AH. Controversies in Nephrology, Pro Position: Too many patients who are too sick to benefit start chronic dialysis; nephrologists need to learn to “just say no”. Am J Kidney Dis 2003; 41:723-732.

86. Kimmel PL, Emont SL, Newmann JM, Danko H, Moss AH. ESRD patient quality of life: Symptoms, spiritual beliefs, psychological factors, and ethnicity. Am J Kidney Dis 2003; 42:713-721.

87. Holley JL, Carmody SS, Moss AH, Sullivan AM, Cohen LM, Block SD, Arnold RM. The need for end-of-life care training in nephrology: National survey results of nephrology fellows. Am J Kidney Dis 2003;42:813-820.

88. Moss AH, Holley JL, Davison SN, Dart RA, Germain MJ, Cohen L, Swartz RD. Core Curriculum in Nephrology: Palliative care. Am J Kidney Dis 2004;43:172-185.

89. King K, Moss AH. The frequency and significance of the “difficult” patient: The nephrology community’s perceptions. Advances in Chronic Kidney Disease 2004;11:234-239.

90. Moss AH. Improving end-of-life care for dialysis patients [Editorial]. Am J Kidney Dis 2005;45:209-212.

91. Michel DM, Moss AH. Communicating Prognosis in the Dialysis Consent Process: A Patient-Centered, Guideline-Supported Approach. Adv Chronic Kidney Dis 2005;12:196-201.

92. Moss AH. End-of-Life Care in West Virginia [Editorial]. West Virginia Medical Journal 2005;101:5.

93. Demanelis AR, Keresztury J, Emmett M, Moss AH. The development and outcomes of a statewide network of hospital-based palliative care teams. J Palliative Med 2005;8:324-332.

94. Hickman S, Hammes BJ, Moss AH, Tolle S. Hope for the Future: Achieving the Original Intent of Advance Directives. Hastings Center Report November 2005 Special Report- Improving End of Life Care: Why Has It Been So Difficult, pp S26-S30.

95. Moss AH, Demanelis AR, Murray J, Jack J. Barriers to quality end-of-life care in West Virginia intensive care units: Physicians’ and nurses’ perspectives. WV Med J. Sept/Oct 2005;101(5):200-204.

96. Fisher II JW, Moss AH. Confronting death in the academy: A dialogue. Univ Toledo Law Review 2005;37:75-80.

97. Murray AM, Arko C, Chen S-C, Gilbertson DT, Moss AH. Utilization of Hospice in the United States Dialysis Population. Clinical J Am Soc Nephrol. 2006;1:1248-1255.

98. Barakzoy AS, Moss AH. Efficacy of the World Health Organization Analgesic Ladder to Treat Pain in End-Stage Renal Disease. J Am Soc Nephrol 2006;17:3198-3203.

99. Cohen LM, Moss AH, Weisbord S, Germain MG. Renal palliative care. J Palliat Med 2006;9:977-992.

100. Davison SN, Jhangri GS, Holley JL, Moss AH. Nephrologists’ reported preparedness for end-of-life decision-making. Clin J Am Soc Nephrol 2006;1:1256-1262.

101. Holley JL, Davison SN, Moss AH. Nephrologists’ changing practices in reported end-life decision-making. Clin J Am Soc Neph 2007;2:107-111.

102. Anantharaman P, Moss AH. Should the Medicare ESRD Program pay for daily dialysis? An ethical analysis. Adv Chronic Kidney Dis 2007;14:290-296.

103. Dunn PM, Tolle SW, Moss AH, Black JS. The POLST Paradigm: Respecting the wishes of patients and families. Annals of Long-term Care 2007;15:33-40.

104. The POLST (Physician Orders for Life-Sustaining Treatment) Paradigm to Improve End-of-Life Care: Potential State Legal Barriers to Implementation. J Law Med Ethics, Spring 2008;36:119-140.

105. Bhargava J, Thompson K, Bachelder R,Bova-Collis R, Moss AH. Hospice and ESRD: Knowledge deficits and underutilization of program benefits. Nephrology Nursing Journal 2008;35:461-466.

106. Hashmi A, Moss AH. Treating disruptive and difficult dialysis patients: Practical strategies based on ethical principles. Nature Clinical Practice Nephrology 2008;4(9):515-520.

107. Moss AH, Ganjoo J, Sharma S, Gansor J, Senft S, Weaner B, Dalton C, MacKay K, Pellegrino B, Anantharaman P, Schmidt R. Utility of the “Surprise” Question to Identify Dialysis Patients with High Mortality. Clin J Am Soc Nephrol 2008;3:1379-1384.

108. Hickman SH, Nelson C, Moss AH, Hammes BJ, Tolle S. Use of the POLST (Physician Orders for Life-Sustaining Treatment) Paradigm Program in the hospice setting. J Palliat Med 2009;12:133-141.

109. Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol. 2009 Feb;4(2):456-60.

110. Moss AH. Prescription opioids and physician responsibility [editorial]. West Virginia Medical Journal 2009; 105:8.

111. Cohen LM, Ruthazer R, Moss AH, Germain MJ. Predicting six-month mortality in patients maintained with hemodialysis. Clin J Am Soc Nephrol

112. Hickman SE, Nelson CA, Perrin N, Moss AH, Hammes BJ, Tolle SW. A comparison of methods to communicate treatment preferences in nursing facilities: Traditional practices versus the Physician Orders for Life-Sustaining Treatment (POLST) program. J Am Geriatr Soc 2010;58:1241–1248.

113. Shaffer EG, Moss AH. Physicians’ perceptions of doctor shopping in West Virginia. West Virginia State Medical Journal 2010;106:10-14.

114. Moss AH, Lunney JR, Culp S, Auber M, Kurian S, Rogers J, Dower J, Abraham J. Prognostic Significance of the “Surprise” Question in Cancer Patients. J Palliat Med 2010;13:837-840.

115. Hashmi A, Cheema M, Moss AH. Hemodialysis patients’ experience with and attitudes toward the buttonhole technique for arteriovenous fistula cannulation. Clin Nephrol 2010;74:346-350.

116. Moss AH. Revised dialysis clinical practice guideline promotes more informed decision-making. Clin J Am Soc Nephrol 2010;5(12): 2380-2383.

117. Moss AH. Completing the continuum of quality care for dementia: End-of-life care. West Virginia Medical Journal 2011;107:34-38.

118. Germain MJ, Davison SN, Moss AH. When enough is enough: The nephrologist’s responsibility to order dialysis. Am J Kidney Dis 2011;58:135-143.

119. Moss AH. Ethical principles and processes guiding dialysis decision-making. Clin J Am Soc Nephrol 2011;6:2313-2317.

120. Hickman SE, Nelson CA, Moss AH,Tolle SW, Perrin NA, Hammes BJ. The Consistency BetweenTreatments Provided to Nursing Facility Residents and Orders on the Physician Orders for Life-Sustaining Treatment (POLST) Form. J Am Geriatr Soc. 2011:2091-2099.

121. Schell J, Bova-Collis R, Deziel S, Moss AH. The patient wants to stop dialysis: The latest evidence on how to respond. Nephrol News Issues 2012;26(4):22-28.

122. Rosen D, Moss AH, Dower J, Parker J. Measuring ICU Palliative Care: Have we set the bar too low? [editorial] Crit Care Med 2012 Apr;40(4):1343-4.

123. Moss AH. To dialyze or not: The patient with metastatic cancer and AKI in the ICU.

Clin J Am Soc Nephrol 2012; 7: 1507–1512.

124. Nephrologists’ Professional Ethics in Dialysis Practices. Clin J Am Soc Nephrol 2013;8:840 844. PMID: 23220423

125. Allon M, Harbert G, Bova-Collis R, Roberts SV, Moss AH. The demented patient who declines to be dialyzed and the unhappy armed police officer son: what should be done? Clin J Am Soc Nephrol. 2014 Apr;9(4):804-8. PMID: 24235284

126. Schmidt R, Moss AH. Dying on dialysis: The case for a dignified withdrawal. Clin J Am Soc Nephrol 2014;9:174-180. PMID: 23970133

127. Akbar S, Moss AH. The ethics of offering dialysis for AKI to the older patient: Time to reevaluate? Clin J Am Soc Nephrol. 2014 9(9): 1652-6. PMID: 24812422

128. Feely MA, Albright RC, Thorsteinsdottir B, Moss AH, Swetz KM., Ethical challenges with hemodialysis patients who lack decision-making capacity: behavioral issues, surrogate decision-makers and end-of-life situations. Kidney Int 2014 Sep; 86(3):475-80. PMID: 24988063

129. O’Hare AM, Armistead N, Funk Schrag W, Diamond L, Moss AH. Patient-centered care: An opportunity to accomplish the “three aims” of the National Quality Strategy in the Medicare ESRD Program. Clin J Am Soc Nephrol 2014; 9:2189-2194. PMID: 25035275

130. Grubbs V, Moss AH, Cohen LM, Fischer MJ, Germain MJ, Jassal SV, Perl J, Weiner DE, Mehrotra R on behalf of the Dialysis Advisory Group of the American Society of Nephrology. A palliative approach to dialysis care: A patient-centered transition to the end of life. Clin J Am Soc Nephrol 2014; 9: 2203–2209. PMID: 25104274

131. Combs SA, Culp S, Matlock DD, Kutner JS, Holley JL, Moss AH. Update on End-of-Life Care Training During Nephrology Fellowship: A Cross-sectional National Survey of

Fellows. Am J Kidney Dis. 2015; 65(2):233-239. PMID: 25245300

132. Moss AH. Davison SN. How the ESRD Quality Incentive Program Could Potentially Improve Quality of Life for Patients on Dialysis. Clin J Am Soc Nephrol 2015: 10:888-893. PMID: 25739850

133. Davison SN, Levin A, Moss AH, Jha V, Brown EA, Brennan F, Murtagh FE, Naicker S, Germain MJ, O'Donoghue DJ, Morton RL, Obrador GT. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney Int. 2015 Sep;88(3):447-459. PMID: 25923985

134. Thomas RA, Curley B, Wen S, Zhang J, Abraham J, Moss AH. Palliative Care Training during Fellowship: A National Survey of U.S. Hematology and Oncology Fellows. J Palliat Med. 2015 Sep;18(9):747-751. PMID:26098204

135. Pedraza SL, Culp S, Falkenstine EC, Moss AH. POST Forms More Than Advance Directives Associated With Out-of-Hospital Death: Insights From a State Registry. J Pain Symptom Manage. 2016 Feb;51:240-246. PMID: 26477827

136. Culp S, Lupu D, Arenella C, Armistead N, Moss AH. Unmet Supportive Care Needs in U.S. Dialysis Centers and Lack of Knowledge of Available Resources to Address Them. J Pain Symptom Manage 2016;51:756-761. PMID: 26706629

137. Moss AH. It takes a system to respect patients’ wishes. WV Medical J. 2016;112:54-58.PMID: 27301156

138. Moss AH, Zive DM, Falkenstine EC, Fromme EK, Tolle SW. POLST Medical Intervention Orders and In-hospital Death Rates: Comparable Patterns in Two State Registries. J Am Geriatr Soc 2016; 64(8):1739-41. PMID: 27345823. [Research Letter]

139. Russell JS, Lupu D, Seliger S, Moss AH. Providing supportive care to patients with kidney disease. Nephrol News Issues 2016;30(5):28, 30, 32. PMID:27382864

140. Scherer JS, Moss AH. Practice change is needed for dialysis decision making for older adults with advanced kidney disease. Clin J Am Soc Nephrol 2016; 11(10):1732-1734. . PMID: 27660307

141. Davison SN, Moss AH. Kidney Supportive Care: Meeting the needs of patients with advanced chronic kidney disease. CJASN 2016;11(10):1879-1880.

142. Moss AH. Integrating Supportive Care Principles into Dialysis Decision-Making: A Primer for Palliative Medicine Providers. J Pain Symptom Manage 2017;53:656-662. PMID: 28065700

143. Brennan F, Stewart C, Burgess H, Davison SN, Moss AH, Murtagh FE, Germain M, Tranter S, Brown M. Time to Improve Informed Consent for Dialysis: An International Perspective. Clin J Am Soc Nephrol. 2017 Apr 4. pii: CJN.09740916. doi: 10.2215/CJN.09740916. [Epub ahead of print] PMID: 28377472

144. O'Hare AM, Song MK, Kurella Tamura M, Moss AH. Research Priorities for Palliative Care for Older Adults with Advanced Chronic Kidney Disease. J Palliat Med. 2017 May;20(5):453-460. PMID: 28463635

145. Hadique S, Culp S, Sangani RG, Chapman KD, Khan S, Parker JE, Moss AH. Derivation

and validation of a prognostic model to predict 6-month mortality in an intensive care unit population. Ann Am Thorac Soc. 2017;14(10):1556-1561. PMID: 28598196

146. Moss AH, Zive DM, Falkenstine EC, Dunithan C. The Quality of POLST Completion to Guide Treatment: A 2-State Study. J Am Med Dir Assoc. 2017 Jun 28. pii: S1525-8610(17)30294-3. doi: 10.1016/j.jamda.2017.05.015. [Epub ahead of print] PMID: 28668665

147. Pedraza SL, Culp S, Knestrick M, Falkenstine E, Moss AH. Association of Physician Orders for Life-Sustaining Treatment Form Use with End-of-Life Care Quality Metrics in Patients with Cancer. J Oncol Pract. 2017 Oct;13(10):e881-e888. PMID: 28727486

148. Constantine L, Dichiacchio T, Falkenstine EC, Moss AH. Impact of NPs on POLST Completion: Findings from a State Registry. JAANP 2018;30(1):10-16

149. Mayoral VFS, Fukushima FB, Rodrigues AM, Carvalho RP, Carvalho LP, Pinheiro LAFV, Polegato BF, Minicucci MF, Bassett R, Moss AH, Steinberg KE, Vidal EIO. Cross –Cultural Adaptation of the Physician Orders for Life-Sustaining Treatment Form to Brazil. J Palliat Med. 2018; 21(6):815-819. PMID: 29431571

150. Tamura MK, O'Hare AM, Lin E, Holdsworth LM, Malcolm E, Moss AH. Palliative care disincentives in CKD: Changing policy to Improve CKD care. Am J Kidney Dis. 2018 Jun;71(6):866-873. PMID: 29510920

151. Schmidt RJ, Landry DL, Cohen L, Moss AH, Dalton C, Nathanson BH, Germain MJ. Derivation and Validation of a Prognostic Model to Predict Mortality in Patients with Advanced Chronic Kidney Disease. Nephrol Dial Transplant. 2018 Nov 5. doi: 10.1093/ndt/gfy305. [Epub ahead of print]. PMID: 30395311

152. Saeed F, Lupu D, Moss AH. The Donut or the Hole? Prioritizing Patient and Caregiver Values in the Delivery of High Quality Medical Management Without Dialysis. Am J Kidney Dis. 2019;73(2):153-155. PMID: 30545706

153. Lovadini GB, Fukushima FB, Schoueri JFL, Dos Reis R, Fonseca CGF, Rodriguez JJC, Coelho CS, Neves AF, Rodrigues AM, Marques MA, Jacinto AF, Harrison Dening K, Bassett R, Moss AH, Steinberg KE, Vidal EIO. Evaluation of the Interrater Reliability of End-of-Life Medical Orders in the Physician Orders for Life-Sustaining Treatment Form. JAMA Netw Open. 2019 Apr 5;2(4):e192036. doi: 10.1001/jamanetworkopen.2019.2036. PMID: 30977852

154. Abudayyeh A, Song J, Abdelrahim M, Dahbour I, Page VD, Zhou S, Shen C, Zhao B, Pai RN, Amaram-Davila J, Manzano JG, George MC, Yennu S, Mandayam SA, Nates JL, Moss AH. Renal Replacement Therapy in Patients With Stage IV Cancer Admitted to the Intensive Care Unit With Acute Kidney Injury at a Comprehensive Cancer Center Was Not Associated With Survival. Am J Hosp Palliat Care. 2020 Jan 27;:1049909120902115. doi: 10.1177/1049909120902115. [Epub ahead of print] PubMed PMID: 31986903.

155. Piamjariyakul U, Petitte T, Smothers A, Wen S, Morrissey E, Young S, Sokos G, Moss AH, Smith CE. Study protocol of coaching end-of-life palliative care for advanced heart failure patients and their family caregivers in rural appalachia: a randomized controlled trial. BMC Palliat Care. 2019 Dec 29;18(1):119. doi: 10.1186/s12904-019-0500-z. PubMed PMID: 31884945; PubMed Central PMCID: PMC6936135.

156. Evaluation of a Video Decision Aid to Reduce Decisional Conflict in Physician Orders for Life-Sustaining Treatment (POLST) Decision-Making. J Palliat Care. 2020;35(4):243-247. PMID: 32372687

157. Funk DC, Moss AH, Speis A. How COVID-19 Changed Advance Care Planning: Insights From the West Virginia Center for End-of-Life Care. J Pain Symptom Manage 2020 Dec;60(6):e5-e9. doi: 10.1016/j.jpainsymman.2020.09.021. Epub 2020 Sep 22. PMID: 32976940

158. Constantine LA, Wang K, Funk D, Speis A, Moss AH. Use of a State Registry to Compare Practices of Physicians and Nurse Practitioners in Completing Physician Orders for Life-Sustaining Treatment Forms.J Palliat Med. 2021;24(7):994-999. doi: 10.1089/jpm.2020.0515. Online ahead of print. PMID: 33259768

159. Diamond LH, Armistead NC, Lupu DE, Moss AH; Steering Committee of the Coalition for Supportive Care of Kidney Patients. Recommendations for Public Policy Changes to Improve Supportive Care for Seriously Ill Patients With Kidney Disease. Am J Kidney Dis. 2021; 77(4):529-537. PMID: 33278476

160. Lovadini GB, Fukushima FB, Schoueri JFL, Reis RD, Fonseca CGF, Rodriguez JJC, Coelho CS, Neves AF, Rodrigues AM, Marques MA, Bassett R, Steinberg KE, Moss AH, Vidal EIO. To What Extent Do Physician Orders for Life-Sustaining Treatment (POLST) Reflect Patients' Preferences for Care at the End of Life? J Am Med Dir Assoc. 2021 Feb;22(2):334-339.e2. doi: 10.1016/j.jamda.2020.10.016. Epub 2020 Nov 13. PMID: 33246840

162. Moss AH, Navia RO. Should we recommend dialysis to older patients with kidney failure and dementia? J Am Geriatr Soc. 2021 Mar 5. doi: 10.1111/jgs.17076. Online ahead of print. PMID: 33666942

163. Corbett CM, Moss AH. Exploring the Evidence: Active Medical Management without Dialysis. Nephrol Nursing J 2021;48(1):69-76.

164. Lupu D, Moss AH. The Role of Kidney Supportive Care and Active Medical Management Without Dialysis in Supporting Well-Being in Kidney Care. Sem Nephrol 2021;41(6):580-591. PMID: 34973702

165. Saeed F, Moss AH, Duberstein PR, Fiscella KA. Enabling Patient Choice: The ‘Deciding Not to Decide’ Option for Older Adults Facing Dialysis Decisions. J Am Soc Nephrol 2022;33(5):880-882. PMID: 35169067

166. Gelfand SL, Fitchett G, Moss AH. Recognizing the Potential Importance of Religion and Spirituality in the Care of Black Americans with Kidney Failure. J Am Soc Nephrol 2022;33(7):1255-1257. PMID: 35304429

167. Kurella Tamura M, Holdsworth L, Stedman M, Aldous A, Asch SM, Han J, Harbert G, Lorenz KA, Malcolm E, Nicklas A, Moss AH, Lupu DE. Implementation and Effectiveness of a Learning Collaborative to Improve Palliative Care for Seriously Ill Hemodialysis Patients. Clin J Am Soc Nephrol. 2022;17(10):1495-1505. PMID: 36104084

168. Haug K, Buffington A, Zelenski A, Hanlon BM, Stalter L, Kwekkeboom KL, Rathouz P, Bansal AD, Cheung K, Crews D, Frazier R, Koncicki H, Lam D, Moss A, Rao M, Wolfgram DF, Yi J, Brill C, Kendrick R, Campbell TC, Jhagroo R, Schwarze M. Best Case/Worst Case: protocol for a multisite randomised clinical trial of a scenario planning intervention for patients with kidney failure. BMJ Open. 2022;12(11):e067258. PMID: 36328383

169. Moss AH. Should the Incapacitated Patient’s Prior Refusal of Dialysis Be Honored? The Value of a Systematic Approach to Gathering Data in an Ethics Consultation. Am J Bioethics 2023; 23 (8): 90-91. DOI: 10.1080/15265161.2023.2218251. PMID: 37450530

170. Miller D, Moss A. Rethinking the Ethics of the Covid-19 Pandemic Lockdowns. Hastings Center Report 2023; 53 (4):3-9. DOI: 10.1002/hast.1495. PMID: 37549359

172. Holdsworth LM, Stedman M, Gustafsson ES, Han J, Asch SM, Harbert G, Lorenz KA, Lupu DE, Malcom E, Moss AH, Nicklas A, Kurella Tamura M. “Diving in the deep-end and swimming”: A mixed methods study using Normalization Process Theory to evaluate a learning collaborative approach for the implementation of palliative care practices in hemodialysis centers. BMC Health Services Research 2023;23:1384. doi: 10.1186/s12913-023-10360-7. PMID: 38082293

173. Umberfield EE, Fields MC, Lenko R, Morgan TP, Adair ES, Fromme EK, Lum HD, Moss AH, Wenger NS, Sudore RL, Hickman SE. An Integrative Review of the State of POLST Science: What Do We Know and Where Do We Go? J Am Med Dir Assoc. 2024 Feb 20:S1525-8610(24)00053-7. doi: 10.1016/j.jamda.2024.01.009. Online ahead of print. PMID: 38395413

AWARDS AND HONORS:

2017 Department of Medicine Outstanding Service Award, West Virginia University School of Medicine

2016 Community Services Award from the Community Living Initiatives Corporation, Morgantown, WV

Certificate of Appreciation for Loyal and Dedicated Service to the Citizens of West Virginia, West Virginia Department of Health and Human Resources, 2015

Medal of Excellence Award, American Association of Kidney Patients, 2015

West Virginia University Benedum Distinguished Scholar Award, 2011

Renal Physicians Association Distinguished Service Award, 2011

West Virginia University School of Medicine Department of Medicine Community Service Award 2009

West Virginia University Hospitals Star Performer Award October 2008

Ethel and Gerry Heebink Award for Distinguished Service to the State of West Virginia granted by West Virginia University-2008

Recognition and Appreciation from the West Virginia Members of the Association of Professional Chaplains-May 2007

American College of Physicians-West Virginia Chapter- Laureate Award-2005

Special Recognition Award for Outstanding Contributions to the Mid-Atlantic Renal Coalition 2005

Centers for Medicare and Medicaid Services Certificate in Recognition of Outstanding Performance and Service 2005

West Virginia Hospital Association 2004 Excellence in Leadership Award

Guest Editor. West Virginia Medical Journal issue on End-of-Life Care including Pain Management. Volume 98, no. 3, May/June 2002.

Friend of Nursing Award. Fifth District Annual Nursing Award of the West Virginia Nurses Association, 2002

West Virginia Health Care Association Presidential Citation, 2001

Excellence in Quality Leadership Award, West Virginia University Hospitals, 2000

Distinguished West Virginian awarded by Governor Cecil Underwood, 2000

West Virginia Hospice Council Advocate of the Year, 2000

National Leadership Training Program for Physicians in Clinical Medical Ethics, Center for Clinical Medical Ethics, University of Chicago Pritzker School of Medicine, 1989-90

"Outstanding Faculty Award", Department of Medicine, West Virginia University School of Medicine, 1984.

"Outstanding Teacher Award", Internal Medicine Residency Program, Moses H. Cone Memorial Hospital, 1981-1983.

GRANTS AND RESEARCH:

Grants Received

1.  Biomedical Research Grant 6680, Principal Investigator, Comparison of plasma metabolites in hemodialysis and CAPD patients, West Virginia University School of Medicine, $4000, 1984.

2.  Limulus amebocyte lysate reactivity and complement C3a activation of cuprophan and cellulose acetate hemodialysis membranes.  Partial funding from Travenol Laboratories, $5000, 1986-1987.

3.  Study of iopamidol nephrotoxicity.  Funding from Squibb Medical Research Institute, $12,000, 1985-1986.

4.  National Leadership Training Program for Physicians in Clinical Medical Ethics. Funding from the Pew Charitable Trusts and the Henry J. Kaiser Family Foundation through the Center for Clinical Medical Ethics, University of Chicago Pritzker School of Medicine, $97,000, 1989-1993.

5.  Home Ventilator Care in Amyotrophic Lateral Sclerosis Patients: Assessment of Outcomes and Patient, Family and Physician Attitudes, University of Chicago Home Health Care Research Program, $20,703, 1989-1990.

6.  West Virginia University Health Science Center Strategic Planning Grant, Intensive Workshop for Faculty on Health Ethics, principal investigator, $1,000, 1991-1992.

7.  Dialysis Decisions and the Elderly. National Kidney Foundation of Western Pennsylvania, principal investigator, $10,515.76, 1995-1996. Co-investigators Laurie A. Badzek, RN, JD, and Stephen C. Hines, PhD

8.  John Templeton Faith and Medicine Competitive Grant Award Program, principal investigator, $25,000 May 15, 1996-1999.  Co-investigators Mary Ann Antonelli, MD, Richard Iammarino, MD, Charles Spring, ThD, Vaughn Michael DMin

9.  Patient-Centered, Family-Based Advance Care Planning, The Greenwall Foundation, principal investigator, $68,753, January 1, 1997. Co-investigators Austin Babrow, PhD, Laurie A. Badzek, RN, JD, Jacqueline J. Glover, PhD, Stephen C. Hines, PhD, and Jean L. Holley, MD

10.   Advanced Health Planning in Home Care: An Intervention to Increase Nurses’ Skills and Preparedness to Discuss End-of-LifeCare with Patients and Families, The Joseph S. and Emily Kornfeld Foundation, $177,181 three-year grant beginning January 1, 1997. Principal investigators Laurie A. Badzek, RN, JD and Jacqueline J. Glover, PhD. Co-investigator Nan Leslie, PhD, RNC.  Alvin H. Moss, MD, general study consultant.

11.  Community State Partnerships to Improve End-of-Life Care: The West Virginia Initiative to Improve End-of-Life Care, The Robert Wood Johnson Foundation, principal investigator, $75,000, January 1, 1999-December 31, 1999.

12.  Community Values for Care at the End-of-Life, The West Virginia Humanities Council, principal investigator, $7,000, January 1, 1999-December 31, 1999

13.  Palliative Care Delivery Systems and Training for Rural Providers in End-of-Life Care, The Claude Worthington Benedum Foundation, principal investigator, $375,000, March 1999-February 2002.

14.  Statewide Media Campaign to Educate West Virginians About End-of-Life Care, The Claude Worthington Benedum Foundation, principal investigator, $85,000, November 1999-October 2001.

15. Community-State Partnerships to Improve End-of-Life Care: The West Virginia Initiative to Improve End-of-Life Care, The Robert Wood Johnson Foundation, principal investigator, $375,000, January 1, 2000-December 31, 2001. 

16. Targeted End-of-Life Projects Initiative: Evaluation of the Effectiveness of a Statewide Media Campaign to Improve End-of-Life Care, The Robert Wood Johnson Foundation, principal investigator, $72,250, January 1, 2000-December 21, 2000.

17. Educating West Virginians about End-of-Life Care Through Community Engagement, West Virginia Humanities Council, principal investigator, $20,000, January 1, 2000-December 31, 2000.

18. West Virginia Palliative Care Network. Center to Advance Palliative Care in Hospitals and Health Systems of the Robert Wood Johnson Foundation, principal investigator, $50,000, February 2001-January 2003.

19. Identification of Patients Appropriate for Palliative Care Consultation. West Virginia University Hospitals Enhancing Patient Care Grant Program, principal investigator, $7,000, April 2001-March 2002.

20. Assessing the Quality of Life of ESRD Patients. University of Montana Promoting Excellence in End-of-Life Care Program, principal investigator, $10,000, August 2001-January 2002.

21. CME Video Project: End-of-Life Care and Pain Management. Purdue Pharma, principal investigator, $20,000, October 2001.

22. West Virginia Center for End-of-Life Care. State of West Virginia. Center Director. $200,000. July 2002-June 2003.

23. Improving End-of-Life Care in West Virginia. Claude Worthington Benedum Foundation. $150,000. January-December 2003.

24. West Virginia Center for End-of-Life Care. State of West Virginia. Center Director. $200,000. July 2003-June 2004.

25. CME Video Project: End-of-Life Care including Pain Management: Beyond the Basics, Purdue Pharma, principal investigator, $5,000, August 2003

26. CME Video Project: End-of-Life Care including Pain Management: Beyond the Basics, Merck, principal investigator, $8,000, August 2003

27. A Multifaceted Approach to Improving End-of-Life Care in West Virginia. Claude Worthington Benedum Foundation. $191,000. January-December 2004.

28. Ensuring the Sustainability of Palliative Care in West Virginia. Claude Worthington Benedum Foundation. $500,000. September 2005-December 2009.

29. Converting Treatment Wishes into Medical Orders at End of Life. National Institute of Nursing Research. 1 R01 NR009784‑01A2. $300,000. September 2005-August 2008. Principal site investigator for multi-site grant and co-investigator on grant.

30. The West Virginia Advance Care Planning Document Electronic Registry. Claude Worthington Benedum Foundation. $100,000. January 1-December 31, 2010.